Literature DB >> 19376833

Binding of estrogen receptor alpha/beta heterodimers to chromatin in MCF-7 cells.

Zoi Papoutsi1, Chunyan Zhao, Milica Putnik, Jan-Ake Gustafsson, Karin Dahlman-Wright.   

Abstract

Estrogen receptors (ERs), ERalpha and ERbeta, belong to a group of transcription factors that, upon ligand binding, regulate gene expression by binding to specific DNA regions in chromatin as dimers. In this article, we applied the sequential chromatin immunoprecipitation assay (Re-ChIP) to study the simultaneous presence of ERalpha and ERbeta on various DNA-binding regions in intact chromatin. ERalpha/beta heterodimers were isolated by precipitation with anti-ERbeta antibody followed by anti-ERalpha antibody from a stable MCF-7-derived cell line that expresses endogenous ERalpha and an inducible version of ERbeta. The Re-ChIP method was first validated based on the detection of ERalpha/beta heterodimers bound to a promoter region of the pS2 gene known to bind both ERalpha and ERbeta. We next examined 12 ER-binding sites using Re-ChIP assays for ERalpha/beta heterodimer recruitment. Our results confirmed the recruitment of ERalpha/beta heterodimers to all these regions. This study represents the first demonstration of binding of ERalpha/beta heterodimers to various DNA-binding regions in intact chromatin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376833     DOI: 10.1677/JME-08-0177

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  17 in total

1.  Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection.

Authors:  Tze Howe Charn; Edison Tak-Bun Liu; Edmund C Chang; Yew Kok Lee; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2009-11-06

Review 2.  Estrogen receptor signaling during vertebrate development.

Authors:  Maria Bondesson; Ruixin Hao; Chin-Yo Lin; Cecilia Williams; Jan-Åke Gustafsson
Journal:  Biochim Biophys Acta       Date:  2014-06-17

Review 3.  Minireview: Estrogen receptor-beta: mechanistic insights from recent studies.

Authors:  Bonnie J Deroo; Adrian V Buensuceso
Journal:  Mol Endocrinol       Date:  2010-04-02

Review 4.  Liganded and unliganded activation of estrogen receptor and hormone replacement therapies.

Authors:  Adriana Maggi
Journal:  Biochim Biophys Acta       Date:  2011-05-14

5.  Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.

Authors:  Aurélie Docquier; Aurélie Garcia; Julien Savatier; Abdel Boulahtouf; Sandrine Bonnet; Virginie Bellet; Muriel Busson; Emmanuel Margeat; Stéphan Jalaguier; Cathy Royer; Patrick Balaguer; Vincent Cavaillès
Journal:  Mol Endocrinol       Date:  2013-07-24

6.  Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.

Authors:  Philip Jonsson; Anne Katchy; Cecilia Williams
Journal:  Endocr Relat Cancer       Date:  2014-01-30       Impact factor: 5.678

7.  Fetal and neonatal exposure to the endocrine disruptor methoxychlor causes epigenetic alterations in adult ovarian genes.

Authors:  Aparna Mahakali Zama; Mehmet Uzumcu
Journal:  Endocrinology       Date:  2009-07-09       Impact factor: 4.736

8.  Fatty acids derived from royal jelly are modulators of estrogen receptor functions.

Authors:  Paraskevi Moutsatsou; Zoi Papoutsi; Eva Kassi; Nina Heldring; Chunyan Zhao; Anna Tsiapara; Eleni Melliou; George P Chrousos; Ioanna Chinou; Andrey Karshikoff; Lennart Nilsson; Karin Dahlman-Wright
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

9.  Progression of luminal breast tumors is promoted by ménage à trois between the inflammatory cytokine TNFα and the hormonal and growth-supporting arms of the tumor microenvironment.

Authors:  Polina Weitzenfeld; Nurit Meron; Tal Leibovich-Rivkin; Tsipi Meshel; Adit Ben-Baruch
Journal:  Mediators Inflamm       Date:  2013-12-04       Impact factor: 4.711

Review 10.  Oestrogen receptors in breast cancer: basic mechanisms and clinical implications.

Authors:  Cecilia Williams; Chin-Yo Lin
Journal:  Ecancermedicalscience       Date:  2013-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.